Guidelines advise less frequent follow-up for neuroendocrine tumours

New guidelines from an international expert panel suggest less-frequent follow-up in the short term, but longer follow-up overall, for completely resected gastroenteropancreatic neuroendocrine tumours (NETs).

Principal author, Professor Eva Segelov, from Monash University and co-founder of the Commonwealth Neuroendocrine Tumour Collaboration, said the guidelines address an area of need for patients and health systems in advising appropriate follow-up based on best current evidence – in the absence of level 1 evidence.